Development and Validation of a Digital Twin-based Clinical Research System (X Town Stage I)
1 other identifier
observational
1,500
1 country
1
Brief Summary
Chronic diseases, characterized by their prolonged duration and slow progression, have emerged as predominant contributors to global morbidity and mortality. The investigators have developed a digital twin-based clinical research system (termed X Town) for chronic diseases, to predict clinical outcomes under various interventions. In this study, the investigators aim to evaluate the reliability of the developed digital twin-based clinical research system in predicting short-term clinical outcomes via virtual and real-world clinical studies.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 18, 2025
CompletedFirst Posted
Study publicly available on registry
March 6, 2025
CompletedStudy Start
First participant enrolled
April 13, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 10, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 10, 2025
CompletedMay 15, 2025
February 1, 2025
3 months
February 18, 2025
May 14, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
The agreement between the simulated short-term clinical outcomes in the virtual clinical studies and the real-world short-term clinical outcomes in the real-world clinical studies
We will use three predefined binary metrics to evaluate the agreement: (1) full statistical significance agreement, defined by effect estimates and CIs of the virtual and real-world clinical studies on the same side of the null; (2) estimate agreement, defined by whether effect estimates for the virtual clinical studies fell within the 95% CI for the real-world clinical study results; (3) standardized difference agreement between treatment effect estimates from the real-world clinical studies and the virtual clinical studies, defined by standardized differences (Reference: JAMA. 2023;329(16):1376-1385. doi:10.1001/jama.2023.4221).
Within 3 months
Study Arms (2)
Virtual clinical studies
Real-world clinical studies
Eligibility Criteria
We will mainly include participants at high-risk of or with chronic diseases.
You may qualify if:
- Age≥18 years old
- Receiving care at a community health service centre
- Able to understand and comply with the study procedures
- Agrees to participate in the study and signs the informed consent form
You may not qualify if:
- Patients with severe mental illness
- Patients expected to be unable to complete follow-ups
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Shanghai 6th People's Hospitallead
- Tsinghua Universitycollaborator
- Shanghai Jiao Tong University School of Medicinecollaborator
Study Sites (1)
Shanghai Health and Medical Center
Wuxi, Jiangsu, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
February 18, 2025
First Posted
March 6, 2025
Study Start
April 13, 2025
Primary Completion
July 10, 2025
Study Completion
August 10, 2025
Last Updated
May 15, 2025
Record last verified: 2025-02